Breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group: aqueous extract of Rheum ribes L. , in 7 days, 5cc every day. Intervention 2: Control group: placebo, in 7 days, 5cc every day.
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with breast cancer Adriamycin, Cytoxan, Taxol (ACT) chemotherapy regimen The first or second course of chemotherapy Patient's satisfaction
Exclusion criteria
Exclusion criteria: Patients with other cancer history History of receiving chemotherapy History of seizure and use of anti-convulsant drugs Nausea and vomiting degree 2 or 3 within 24 hours prior to chemotherapy Persistent, moderate or severe nausea Hepatitis or gastrointestinal obstruction and metastasis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of nausea. Timepoint: 8 days after receiving chemotherapy. Method of measurement: National Chemotherapy Institute (NCI) table of nausea grade. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of nausea. Timepoint: 8 days after chemotherapy. Method of measurement: How many days have nausea.;Frequency of vomiting. Timepoint: 8 days after chemotherapy. Method of measurement: National Chemotherapy Institute (NCI) table of vomiting grade. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlimohammad RanjbarJamalabadi
Yazd University of Medical Sciences
Outcome results
None listed